Stephen Doster

by Marissa Shapiro Feb. 17, 2021, 9:00 AM Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens… Read More

Vanderbilt chemist wins Sloan Research Fellowship by Ann Marie Deer Owens Feb. 16, 2021, 9:22 AM Assistant Professor of Chemistry Steven Townsend (Susan Urmy/Vanderbilt) Assistant Professor of Chemistry Steven D. Townsend, PhD’10, has been awarded a 2021 Sloan Research Fellowship, one… Read More

by Marissa Shapiro Feb. 12, 2021, 9:00 AM Bruce Carter (Vanderbilt University) Bruce Carter, professor of biochemistry and an associate director of the Vanderbilt Brain Institute, has been appointed to the scientific advisory board of the CMT Research Foundation. He joins… Read More

by Marissa Shapiro Feb. 11, 2021, 9:00 AM Vanderbilt researchers have identified the protein receptor in specialized heart cells that, when removed, preserves cardiac function after a heart attack. This discovery has significant implications for survival after a heart attack, with a promising therapeutic… Read More

Biomedical researchers across Vanderbilt University will convene to discuss the history and impact of Black biomedical scientists on Monday, Feb. 15, at noon CT. The virtual discussion, “From Inclusion to Equity: The Story of Black Biomedical Scientists,” will be moderated by Dr. André L. Churchwell, vice chancellor for equity, diversity… Read More

A Vanderbilt University Medical Center licensee, Evotec SE, announced on January 28, 2020 that EVT894, a monoclonal antibody to treat and potentially prevent chikungunya virus infections, has entered clinical development. The Phase I, randomised, double-blind, single centre, single dose escalation study to evaluate the safety, pharmacokinetics, and immunogenicity of EVT894 vs… Read More

Feb. 4, 2021, 9:00 AM by Leigh MacMillan Transcription factors — proteins that regulate gene expression — play critical roles in cell fate decisions and are frequent targets of mutation in a variety of human cancers. Understanding how transcription factors contribute to disease requires the identification of their direct gene targets, but traditional methods are time-consuming… Read More

by Melanie Moran Jan. 31, 2021, 1:31 PM Leaves pathbreaking legacy of leadership and discovery at Vanderbilt University Susan R. Wente, provost and vice chancellor for academic affairs (Vanderbilt University) Susan R. Wente, provost and vice chancellor for academic affairs, will become president… Read More

Vivian Gama, assistant professor of cell and developmental biology, and Leon Bellan, associate professor of mechanical engineering and biomedical engineering, have won a $2.3 million, three-year grant from the National Institutes of Health Brain Research through Advancing Innovative Neurotechnologies Initiative.  Vivian Gama Leon Bellan (Vanderbilt University) The researchers will be developing three-dimensional brain organoids and related tissue—miniaturized… Read More

Jan. 28, 2021, 10:05 AM by Bill Snyder Researchers at Vanderbilt University Medical Center and the University of Texas Medical Branch (UTMB) at Galveston have discovered what may be the Achilles’ heel of the coronavirus, a finding that may help close the door on COVID-19 and possibly head off future… Read More